0
Articles |

Tumor Doubling Time and Survival of Men with Bronchogenic Carcinoma FREE TO VIEW

William Weiss
Author and Funding Information

Professor of Medicine, Hahnemann Medical College and Clinical Director, Pulmonary Disease Service, Philadelphia General Hospital


1974, by the American College of Chest Physicians


Chest. 1974;65(1):3-8. doi:10.1378/chest.65.1.3
Text Size: A A A
Published online

Abstract

The relationship between tumor volume doubling time and survival was studied in 28 patients with histologically confirmed bronchogenic carcinoma with the following characteristics: the cancers presented radiographically as circumscribed peripheral nodules first observed at a diameter of 0.6 to 1.4 cm, and follow-up was maintained until death or for at least 8.5 years from the time the tumor was 1.0 cm in diameter. Among eight patients whose cancers were not resected, survival was longer in the four treated with radiation than in the four who were not. Among 20 patients whose cancers were resected, 18 who died showed a fair correlation between tumor doubling time and survival; the other two patients were still alive 116 and 143 months after the tumors were 1 cm in diameter, presumably cured. These observations indicate that tumor growth rate is an important factor in the prognosis of patients with bronchogenic carcinoma.


Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543